{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:24:59Z","timestamp":1767705899810,"version":"build-2065373602"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.cpet.2021.12.002","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T07:47:41Z","timestamp":1645861661000},"page":"249-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["18F-fluorodeoxyglucose PET\/Computed Tomography"],"prefix":"10.1016","volume":"17","author":[{"given":"Stephen M.","family":"Broski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie T.","family":"Packard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher H.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"WHO classification of head and neck tumours","author":"El-Naggar","key":"10.1016\/j.cpet.2021.12.002_bib1"},{"issue":"3","key":"10.1016\/j.cpet.2021.12.002_bib2","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1177\/014556131709600319","article-title":"The rising incidence of major salivary gland cancer in the United States","volume":"96","author":"Del Signore","year":"2017","journal-title":"Ear Nose Throat J"},{"issue":"9","key":"10.1016\/j.cpet.2021.12.002_bib3","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/cncr.29231","article-title":"Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma","volume":"121","author":"Chowdhry","year":"2015","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.cpet.2021.12.002_bib4","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1465::AID-CNCR4>3.0.CO;2-A","article-title":"Salivary gland tumors among atomic bomb survivors, 1950-1987","volume":"79","author":"Saku","year":"1997","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.cpet.2021.12.002_bib5","first-page":"63","article-title":"Warthin's tumour and smoking","volume":"1","author":"de Ru","year":"2005","journal-title":"B-ENT"},{"issue":"1","key":"10.1016\/j.cpet.2021.12.002_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/00016489.2015.1081276","article-title":"Demographics of benign parotid tumours: Warthin's tumour versus other benign salivary tumours","volume":"136","author":"Patel","year":"2016","journal-title":"Acta Otolaryngol"},{"issue":"4","key":"10.1016\/j.cpet.2021.12.002_bib7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1055-9965.EPI-16-0520","article-title":"Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992-2013","volume":"26","author":"Noone","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.cpet.2021.12.002_bib8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/0194599815586764","article-title":"Incidental parotid neoplasms: pathology and prevalence","volume":"153","author":"Britt","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.cpet.2021.12.002_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/(SICI)1097-0339(199609)15:3<185::AID-DC2>3.0.CO;2-G","article-title":"Fine-needle aspiration biopsy in the diagnosis of parotid gland lesions: evaluation of 438 biopsies","volume":"15","author":"Atula","year":"1996","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"10.1016\/j.cpet.2021.12.002_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1368-8375(03)00104-0","article-title":"Management of malignant sublingual salivary gland tumors","volume":"40","author":"Rinaldo","year":"2004","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2021.12.002_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.coms.2015.07.004","article-title":"Benign pediatric salivary gland lesions","volume":"28","author":"Carlson","year":"2016","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"1","key":"10.1016\/j.cpet.2021.12.002_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nic.2012.08.009","article-title":"Pitfalls in the staging of cancer of the major salivary gland neoplasms","volume":"23","author":"Friedman","year":"2013","journal-title":"Neuroimaging Clin N Am"},{"issue":"5","key":"10.1016\/j.cpet.2021.12.002_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1053\/j.sult.2019.07.003","article-title":"FDG-PET imaging of salivary gland tumors","volume":"40","author":"Larson","year":"2019","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.cpet.2021.12.002_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1102\/1470-7330.2007.0008","article-title":"Imaging of salivary gland tumours","volume":"7","author":"Thoeny","year":"2007","journal-title":"Cancer Imaging"},{"issue":"3","key":"10.1016\/j.cpet.2021.12.002_bib15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2214\/ajr.174.3.1740837","article-title":"Imaging-based nodal classification for evaluation of neck metastatic adenopathy","volume":"174","author":"Som","year":"2000","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.cpet.2021.12.002_bib16","first-page":"415","article-title":"Utility of metabolic heterogeneity factor in differentiating malignant versus benign parotid uptake on (18)F FDG PET-CT","volume":"8","author":"Alipour","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2021.12.002_bib17","first-page":"295","article-title":"Diagnostic role of (18)F-FDG-PET or PET\/CT in salivary gland tumors: a systematic review","volume":"34","author":"Bertagna","year":"2015","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"2","key":"10.1016\/j.cpet.2021.12.002_bib18","doi-asserted-by":"crossref","first-page":"W185","DOI":"10.2214\/AJR.11.7172","article-title":"Parotid gland tumors: preliminary data for the value of FDG PET\/CT diagnostic parameters","volume":"198","author":"Hadiprodjo","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.cpet.2021.12.002_bib19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1245\/s10434-012-2716-5","article-title":"Utility of 18F-FDG PET\/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection","volume":"20","author":"Kim","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2021.12.002_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02489988","article-title":"Retrospective review: usefulness of a number of imaging modalities including CT, MRI, technetium-99m pertechnetate scintigraphy, gallium-67 scintigraphy and F-18-FDG PET in the differentiation of benign from malignant parotid masses","volume":"24","author":"Ozawa","year":"2006","journal-title":"Radiat Med"},{"issue":"2","key":"10.1016\/j.cpet.2021.12.002_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13139-012-0135-y","article-title":"Diagnostic Criteria on (18)F-FDG PET\/CT for differentiating benign from malignant focal hypermetabolic lesions of parotid gland","volume":"46","author":"Park","year":"2012","journal-title":"Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.cpet.2021.12.002_bib22","first-page":"187","article-title":"Does 18F-FDG PET\/CT play a role in the differential diagnosis of parotid masses","volume":"47","author":"Rubello","year":"2005","journal-title":"Panminerva Med"},{"issue":"5","key":"10.1016\/j.cpet.2021.12.002_bib23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12149-016-1068-9","article-title":"Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors","volume":"30","author":"Kim","year":"2016","journal-title":"Ann Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2021.12.002_bib24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2214\/AJR.15.15590","article-title":"Is there a role for PET\/CT parameters to characterize benign, malignant, and metastatic parotid tumors?","volume":"207","author":"Kendi","year":"2016","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.cpet.2021.12.002_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.clinimag.2015.03.011","article-title":"Clinical significance of parotid gland incidentalomas on (18)F-FDG PET\/CT","volume":"39","author":"Makis","year":"2015","journal-title":"Clin Imaging"},{"issue":"8","key":"10.1016\/j.cpet.2021.12.002_bib26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s12149-008-0162-z","article-title":"Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas","volume":"22","author":"Horiuchi","year":"2008","journal-title":"Ann Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2021.12.002_bib27","first-page":"27","article-title":"Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography\/computed tomography in sublingual and submandibular salivary gland tumors","volume":"13","author":"Ma","year":"2020","journal-title":"Mol Clin Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2021.12.002_bib28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2214\/AJR.12.10395","article-title":"Can dual-time-point 18F-FDG PET\/CT differentiate malignant salivary gland tumors from benign tumors?","volume":"201","author":"Toriihara","year":"2013","journal-title":"AJR Am J Roentgenol"},{"year":"2017","series-title":"AJCC cancer staging manual","author":"Amin","key":"10.1016\/j.cpet.2021.12.002_bib29"},{"issue":"8","key":"10.1016\/j.cpet.2021.12.002_bib30","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s12149-019-01362-9","article-title":"Up-front F18-FDG PET\/CT in suspected salivary gland carcinoma","volume":"33","author":"Westergaard-Nielsen","year":"2019","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.cpet.2021.12.002_bib31","first-page":"1","article-title":"Surgical anatomy of the lymphatic drainage of the salivary glands: a systematic review","author":"Abou-Foul","year":"2020","journal-title":"J\u00a0Laryngol Otol"},{"issue":"12","key":"10.1016\/j.cpet.2021.12.002_bib32","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1245\/s10434-015-4454-y","article-title":"Distant metastases in patients with carcinoma of the major salivary glands","volume":"22","author":"Ali","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2021.12.002_bib33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.rlu.0000257336.69537.cb","article-title":"FDG PET in detecting primary and recurrent malignant salivary gland tumors","volume":"32","author":"Cermik","year":"2007","journal-title":"Clin Nucl Med"},{"issue":"8","key":"10.1016\/j.cpet.2021.12.002_bib34","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2967\/jnumed.107.041350","article-title":"Role of 18F-FDG PET\/CT in management of high-grade salivary gland malignancies","volume":"48","author":"Jeong","year":"2007","journal-title":"J\u00a0Nucl Med"},{"issue":"6","key":"10.1016\/j.cpet.2021.12.002_bib35","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2967\/jnumed.111.098384","article-title":"Diagnostic value of neck node status using 18F-FDG PET for salivary duct carcinoma of the major salivary glands","volume":"53","author":"Kim","year":"2012","journal-title":"J\u00a0Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2021.12.002_bib36","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s13139-013-0222-8","article-title":"The value of F-18 FDG PET for planning treatment and detecting recurrence in malignant salivary gland tumors: comparison with conventional imaging studies","volume":"47","author":"Park","year":"2013","journal-title":"Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.cpet.2021.12.002_bib37","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/lary.20829","article-title":"Positron emission tomography-computed tomography adds to the management of salivary gland malignancies","volume":"120","author":"Razfar","year":"2010","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.cpet.2021.12.002_bib38","first-page":"240","article-title":"Clinical utility of 18F-FDG PET for patients with salivary gland malignancies","volume":"48","author":"Roh","year":"2007","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2021.12.002_bib39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MNM.0b013e32835bc4c4","article-title":"Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience","volume":"34","author":"Sharma","year":"2013","journal-title":"Nucl Med Commun"},{"issue":"12","key":"10.1016\/j.cpet.2021.12.002_bib40","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/RLU.0000000000002287","article-title":"Pretreatment primary tumor and nodal SUVmax values on 18F-FDG PET\/CT images predict prognosis in patients with salivary gland carcinoma","volume":"43","author":"Hsieh","year":"2018","journal-title":"Clin Nucl Med"},{"issue":"9","key":"10.1016\/j.cpet.2021.12.002_bib41","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/RLU.0000000000001740","article-title":"Pretreatment primary tumor SUVmax on 18F-FDG PET\/CT images predicts outcomes in patients with salivary gland carcinoma treated with definitive intensity-modulated radiation therapy","volume":"42","author":"Hsieh","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2021.12.002_bib42","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.21873\/anticanres.13211","article-title":"Uptake of (18)F-Fluorodeoxyglucose in Major salivary gland cancer predicts survival adjusting for pathological stage","volume":"39","author":"Suzuki","year":"2019","journal-title":"Anticancer Res"},{"issue":"7","key":"10.1016\/j.cpet.2021.12.002_bib43","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2967\/jnumed.112.116053","article-title":"Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by F-18-FDG PET\/CT in Salivary Gland Carcinomas","volume":"54","author":"Ryu","year":"2013","journal-title":"J\u00a0Nucl Med"},{"issue":"12","key":"10.1016\/j.cpet.2021.12.002_bib44","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00432-018-2760-z","article-title":"Pre-treatment metabolic tumor volume predicts tumor metastasis and progression in high-grade salivary gland carcinoma","volume":"144","author":"Almuhaimid","year":"2018","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.cpet.2021.12.002_bib45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.oraloncology.2017.12.013","article-title":"Prediction of distant metastasis and survival in adenoid cystic carcinoma using quantitative (18)F-FDG PET\/CT measurements","volume":"77","author":"Lim","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.cpet.2021.12.002_bib46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinimag.2018.09.021","article-title":"Pretreatment quantitative (18)F-FDG PET\/CT parameters as a predictor of survival in adenoid cystic carcinoma of the salivary glands","volume":"53","author":"Gencturk","year":"2019","journal-title":"Clin Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2021.12.002_bib47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/RLU.0000000000002530","article-title":"Prognostic value of tumor heterogeneity and SUVmax of pretreatment 18F-FDG PET\/CT for salivary gland carcinoma with high-risk histology","volume":"44","author":"Cheng","year":"2019","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2021.12.002_bib48","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13550-019-0555-0","article-title":"Texture analysis of pretreatment [(18)F]FDG PET\/CT for the prognostic prediction of locally advanced salivary gland carcinoma treated with interstitial brachytherapy","volume":"9","author":"Wu","year":"2019","journal-title":"EJNMMI Res"},{"issue":"7","key":"10.1016\/j.cpet.2021.12.002_bib49","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.bjoms.2010.09.013","article-title":"Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma","volume":"49","author":"Ghosal","year":"2011","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"11","key":"10.1016\/j.cpet.2021.12.002_bib50","article-title":"(18)F-FDG PET\/CT for response assessment in pediatric sebaceous carcinoma of the parotid gland","volume":"10","author":"Holzgreve","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.cpet.2021.12.002_bib51","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000488669","article-title":"Second-line treatment of HER2-positive salivary gland tumor: ado-trastuzumab emtansine (T-DM1) after Progression on Trastuzumab","volume":"11","author":"Correa","year":"2018","journal-title":"Case Rep Oncol"},{"issue":"6","key":"10.1016\/j.cpet.2021.12.002_bib52","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/odi.12877","article-title":"Detection of distant metastasis and prognostic prediction of recurrent salivary gland carcinomas using (18) F-FDG PET\/CT","volume":"24","author":"Lee","year":"2018","journal-title":"Oral Dis"},{"issue":"12","key":"10.1016\/j.cpet.2021.12.002_bib53","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1007\/s00405-014-3308-8","article-title":"Prevalence and risk of malignancy of focal incidental uptake detected by fluorine-18-fluorodeoxyglucose positron emission tomography in the parotid gland: a meta-analysis","volume":"272","author":"Treglia","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"10.1016\/j.cpet.2021.12.002_bib54","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00330-014-3397-1","article-title":"Incidental focal FDG uptake in the parotid glands on PET\/CT in patients with head and neck malignancy","volume":"25","author":"Seo","year":"2015","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.cpet.2021.12.002_bib55","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MNM.0000000000000961","article-title":"Parotid incidentalomas on positron emission tomography: what is their clinical significance?","volume":"40","author":"Barbara","year":"2019","journal-title":"Nucl Med Commun"},{"issue":"9","key":"10.1016\/j.cpet.2021.12.002_bib56","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/MNM.0000000000000543","article-title":"Focal fluorine-18 fluorodeoxyglucose-avid parotid findings in patients with lung cancer: prevalence and characteristics","volume":"37","author":"Davidson","year":"2016","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1016\/j.cpet.2021.12.002_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07357907.2014.979365","article-title":"Warthin's tumors and their relationship to lung cancer","volume":"33","author":"White","year":"2015","journal-title":"Cancer Invest"},{"issue":"5","key":"10.1016\/j.cpet.2021.12.002_bib58","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ijrobp.2018.12.009","article-title":"Perineural invasion and perineural tumor spread in head and neck cancer","volume":"103","author":"Bakst","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.cpet.2021.12.002_bib59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.rmr.0000130601.57619.bd","article-title":"Magnetic resonance imaging of perineural spread of head and neck malignancies","volume":"15","author":"Gandhi","year":"2004","journal-title":"Top Magn Reson Imaging"},{"issue":"3","key":"10.1016\/j.cpet.2021.12.002_bib60","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2967\/jnumed.118.214312","article-title":"An imager's guide to perineural tumor spread in head and neck cancers: radiologic footprints on (18)F-FDG PET, with CT and MRI correlates","volume":"60","author":"Lee","year":"2019","journal-title":"J\u00a0Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2021.12.002_bib61","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/0972-3919.190798","article-title":"Common patterns of perineural spread in head-neck squamous cell carcinoma identified on fluoro-deoxy-glucose positron emission tomography\/computed tomography","volume":"31","author":"Chandra","year":"2016","journal-title":"Indian J Nucl Med"},{"issue":"6","key":"10.1016\/j.cpet.2021.12.002_bib62","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1148\/rg.336135501","article-title":"Perineural spread in head and neck malignancies: clinical significance and evaluation with 18F-FDG PET\/CT","volume":"33","author":"Paes","year":"2013","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.cpet.2021.12.002_bib63","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.mric.2012.05.006","article-title":"Patterns of perineural tumor spread in head and neck cancer","volume":"20","author":"Moonis","year":"2012","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"11","key":"10.1016\/j.cpet.2021.12.002_bib64","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.oraloncology.2009.07.001","article-title":"Perineural invasion in adenoid cystic carcinoma of the salivary glands: a valid prognostic indicator?","volume":"45","author":"Barrett","year":"2009","journal-title":"Oral Oncol"},{"issue":"16","key":"10.1016\/j.cpet.2021.12.002_bib65","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1002\/cncr.26697","article-title":"Prognostic factors in mucoepidermoid carcinoma of the salivary glands","volume":"118","author":"McHugh","year":"2012","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.cpet.2021.12.002_bib66","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0901-5027(88)80030-4","article-title":"The significance of perineural spread in adenoid cystic carcinoma of the major and minor salivary glands","volume":"17","author":"Vrielinck","year":"1988","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"7","key":"10.1016\/j.cpet.2021.12.002_bib67","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.joms.2005.03.006","article-title":"Management and outcome of patients with malignant salivary gland tumors","volume":"63","author":"Bell","year":"2005","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.cpet.2021.12.002_bib68","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0360-3016(95)00122-F","article-title":"The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation","volume":"32","author":"Garden","year":"1995","journal-title":"Int J Radiat Oncology\u2217Biology\u2217Physics"},{"issue":"3","key":"10.1016\/j.cpet.2021.12.002_bib69","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4103\/ijnm.IJNM_39_17","article-title":"Perineural spread of mucoepidermoid carcinoma of parotid gland involving v, vi, and vii cranial nerves demonstrated on positron emission tomography\/computed tomography","volume":"32","author":"Chandra","year":"2017","journal-title":"Indian J Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2021.12.002_bib70","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00330-017-5063-x","article-title":"Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies","volume":"28","author":"Dercle","year":"2018","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.cpet.2021.12.002_bib71","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00268-005-0544-5","article-title":"Expression of prostate-specific membrane antigen in normal and malignant human tissues","volume":"30","author":"Kinoshita","year":"2006","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.cpet.2021.12.002_bib72","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.cpet.2021.12.002_bib73","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s13139-016-0445-6","article-title":"68)Ga-PSMA PET-CT imaging of metastatic adenoid cystic carcinoma","volume":"51","author":"de Keizer","year":"2017","journal-title":"Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.cpet.2021.12.002_bib74","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/RLU.0000000000001220","article-title":"In\u00a0Vivo Visualization of prostate-specific membrane antigen in adenoid cystic carcinoma of the salivary gland","volume":"41","author":"Lutje","year":"2016","journal-title":"Clin Nucl Med"},{"issue":"9","key":"10.1016\/j.cpet.2021.12.002_bib75","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/RLU.0000000000003204","article-title":"68Ga-Prostate-Specific Membrane Antigen-11-Avid Cardiac Metastases in a Patient With Adenoid Cystic Carcinoma, A Rare Presentation of a Rare Cancer","volume":"45","author":"Uijen","year":"2020","journal-title":"Clin Nucl Med"},{"issue":"10","key":"10.1016\/j.cpet.2021.12.002_bib76","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1007\/s00259-017-3737-x","article-title":"Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis","volume":"44","author":"Klein Nulent","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2021.12.002_bib77","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.7150\/thno.38501","article-title":"68)Ga-PSMA-HBED-CC PET\/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging study","volume":"10","author":"van Boxtel","year":"2020","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.cpet.2021.12.002_bib78","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00432-021-03538-1","article-title":"The potential of somatostatin receptor 2 as a novel therapeutic target in salivary gland malignant tumors","volume":"147","author":"Meirovitz","year":"2021","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"7","key":"10.1016\/j.cpet.2021.12.002_bib79","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/RLU.0000000000002133","article-title":"68Ga-DOTA-TOC uptake in pleomorphic adenoma","volume":"43","author":"Laurens","year":"2018","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2021.12.002_bib80","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-019-0362-2","article-title":"Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities","volume":"17","author":"Wang","year":"2019","journal-title":"Cell Commun Signal"},{"issue":"12","key":"10.1016\/j.cpet.2021.12.002_bib81","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1007\/s00259-020-04859-y","article-title":"Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers","volume":"47","author":"Syed","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2021.12.002_bib82","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2967\/jnumed.120.244723","article-title":"Fibroblast activation protein-targeted PET\/CT with (68)Ga-FAPI for imaging IgG4-related disease: comparison to (18)F-FDG PET\/CT","volume":"62","author":"Luo","year":"2021","journal-title":"J\u00a0Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2021.12.002_bib83","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s13244-014-0349-x","article-title":"FDG-PET\/CT pitfalls in oncological head and neck imaging","volume":"5","author":"Purohit","year":"2014","journal-title":"Insights Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2021.12.002_bib84","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1148\/rg.245035725","article-title":"PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake","volume":"24","author":"Kostakoglu","year":"2004","journal-title":"Radiographics"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859821001103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859821001103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:08:21Z","timestamp":1761563301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859821001103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1556859821001103"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2021.12.002","relation":{},"ISSN":["1556-8598"],"issn-type":[{"type":"print","value":"1556-8598"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"18F-fluorodeoxyglucose PET\/Computed Tomography","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2021.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}